Phu Xuan University Library
Pharmacology for Nurses

External

Pharmacology for Nurses

Pharmacology for Nurses is intended for nursing students in an introductory program. It provides a fundamental understanding of the therapeutic use of drugs, so the nurse can provide safe and effective care to the client. Along with a discussion of each body system, the text also reviews the pathophysiology of various disease processes and medications used in treatment.

Author
Openstax
Publisher
LibreTexts
Source
LibreTexts
License
CC BY
Language
EN
Contents· 405 sections
  1. 01: Introduction to Pharmacology
  2. 1.00: Introduction
  3. 1.01: Pharmacology Interdisciplinary Teams and Nursing Practice
  4. 1.02: Drug Sources Forms and Names
  5. 1.03: Drug Classifications and Prototypes
  6. 1.04: Special Considerations
  7. 1.05: Chapter Summary
  8. 1.06: Key Terms
  9. 1.07: Review Questions
  10. 02: Drug Administration
  11. 2.00: Introduction
  12. 2.01: Drug Administration and the Nursing Process
  13. 2.02: Pharmacokinetics and Pharmacodynamics
  14. 2.03: Drug Administration Routes Preparation and Administration
  15. 2.04: Dosage Calculations
  16. 2.05: Chapter Summary
  17. 2.06: Key Terms
  18. 2.07: Review Questions
  19. 03: Ethics Legal Considerations and Safety
  20. 3.00: Introduction
  21. 3.01: Legal Considerations
  22. 3.02: Drug Errors and Prevention
  23. 3.03: Documentation and Informatics
  24. 3.04: Chapter Summary
  25. 3.05: Key Terms
  26. 3.06: Review Questions
  27. 04: Introduction to Homeostasis
  28. 4.00: Introduction
  29. 4.01: What Is Homeostasis
  30. 4.02: Osmolality
  31. 4.03: Maintaining Homeostasis
  32. 4.04: Negative Feedback Loop
  33. 4.05: Chapter Summary
  34. 4.06: Key Terms
  35. 4.07: Review Questions
  36. 05: Fluids and Electrolytes Vitamins Minerals and Alternative Therapies
  37. 5.00: Introduction
  38. 5.01: Fluid Volume
  39. 5.02: Electrolytes
  40. 5.03: Intravenous Fluid Therapy Total Parenteral Nutrition and Blood Products
  41. 5.04: Vitamins Minerals and Complementary and Alternative Therapies
  42. 5.05: Chapter Summary
  43. 5.06: Key Terms
  44. 5.07: Review Questions
  45. 06: Introduction to the Immune System and the Inflammatory Response
  46. 6.00: Introduction
  47. 6.01: Introduction to Immunity
  48. 6.02: Vaccine-Preventable Diseases Vaccines and Immunizations
  49. 6.03: Immunosuppressants Biologics Monoclonal Antibodies and Biosimilar Drugs
  50. 6.04: Introduction to the Inflammatory Response and Anti-inflammatory Drugs
  51. 6.05: Chapter Summary
  52. 6.06: Key Terms
  53. 6.07: Review Questions
  54. 07: Anti-Infective Drugs
  55. 7.00: Introduction
  56. 7.01: Introduction to Bacterial Viral COVID-19 and Fungal Infections
  57. 7.02: Antibiotic Antiviral AntiCOVID-19 and Antifungal Drugs
  58. 7.03: Introduction to HIV AIDS and Antiretrovirals
  59. 7.04: Introduction to Sexually Transmitted Infections and Drugs to Treat Them
  60. 7.05: Introduction to Tuberculosis and Antitubercular Drugs
  61. 7.06: Antiparasitic and Anthelminthic Drugs
  62. 7.07: Chapter Summary
  63. 7.08: Key Terms
  64. 7.09: Review Questions
  65. 08: Introduction to Cancer Therapy and Cancer Drugs
  66. 8.00: Introduction
  67. 8.01: Introduction to Cancer and Phases of Cancer Therapy
  68. 8.02: Chemotherapeutic Drugs
  69. 8.03: Hormonal Therapy
  70. 8.04: Biologic Response Modifiers
  71. 8.05: Chapter Summary
  72. 8.06: Key Terms
  73. 8.07: Review Questions
  74. 09: Introduction to the Nervous System
  75. 9.00: Introduction
  76. 9.01: Introduction to the Nervous System
  77. 9.02: Structure and Function of the Nervous System
  78. 9.03: Characteristics of Drugs to Treat Nervous System Disorders
  79. 9.04: Chapter Summary
  80. 9.05: Key Terms
  81. 9.06: Review Questions
  82. 10: Drugs to Treat Myasthenia Gravis and Alzheimers Disease
  83. 10.00: Introduction
  84. 10.01: Introduction to Myasthenia Gravis
  85. 10.02: Cholinergic Drugs
  86. 10.03: Introduction to Alzheimer's Disease
  87. 10.04: Alzheimers Drugs
  88. 10.05: Chapter Summary
  89. 10.06: Key Terms
  90. 10.07: Review Questions
  91. 11: Drugs to Treat Parkinsons Disease and Multiple Sclerosis
  92. 11.00: Introduction
  93. 11.01: Introduction to Parkinsons Disease
  94. 11.02: Anti-Parkinsonian Drugs
  95. 11.03: Introduction to Multiple Sclerosis
  96. 11.04: Drugs Used in the Treatment of Multiple Sclerosis
  97. 11.05: Chapter Summary
  98. 11.06: Key Terms
  99. 11.07: Review Questions
  100. 12: Anticonvulsant Drugs and Drugs to Treat Epilepsy Migraine Headaches and Intracranial Emergencies
  101. 12.00: Introduction
  102. 12.01: Epilepsy and Anticonvulsant Drugs
  103. 12.02: Migraine Headaches and Migraine Headache Drugs
  104. 12.03: Intracranial Emergencies and Intracranial Emergency Drugs
  105. 12.04: Chapter Summary
  106. 12.05: Key Terms
  107. 12.06: Review Questions
  108. 13: Psychopharmacologic Drugs
  109. 13.00: Introduction
  110. 13.01: Antidepressants
  111. 13.02: Antipsychotics
  112. 13.03: Mood Stabilizers
  113. 13.04: Anxiolytics and Sedative-Hypnotics
  114. 13.05: CNS Stimulants and Nonstimulants
  115. 13.06: Chapter Summary
  116. 13.07: Key Terms
  117. 13.08: Review Questions
  118. 14: Pain Response Drugs
  119. 14.00: Introduction
  120. 14.01: Introduction to Pain
  121. 14.02: Nonopioid Analgesics
  122. 14.03: Opioid Agonists and Antagonists
  123. 14.04: Chapter Summary
  124. 14.05: Key Terms
  125. 14.06: Review Questions
  126. 15: Substance Use Disorder Treatment Drugs
  127. 15.00: Introduction
  128. 15.01: Introduction to Substance Use Disorders
  129. 15.02: Opioid Use Disorder Drugs
  130. 15.03: Alcohol Use Disorder Drugs
  131. 15.04: Nicotine Use Disorder Drugs
  132. 15.05: Chapter Summary
  133. 15.06: Key Terms
  134. 15.07: Review Questions
  135. 16: Introduction to the Cardiovascular System
  136. 16.00: Introduction
  137. 16.01: Introduction to the Heart Circulation and Blood Flow
  138. 16.02: Pumping Action of the Heart
  139. 16.03: Conduction of Electrical Impulses
  140. 16.04: Chapter Summary
  141. 16.05: Key Terms
  142. 16.06: Review Questions
  143. 17: Antidysrhythmic Drugs
  144. 17.00: Introduction
  145. 17.01: Introduction to Dysrhythmias
  146. 17.02: Class I- Sodium Channel Blockers
  147. 17.03: Class II- Beta Adrenergic Blockers
  148. 17.04: Class III- Potassium Channel Blockers
  149. 17.05: Class IV- Calcium Channel Blockers
  150. 17.06: Unclassified Antidysrhythmics
  151. 17.07: Chapter Summary
  152. 17.08: Key Terms
  153. 17.09: Review Questions
  154. 18: Antihypertensive and Antianginal Drugs
  155. 18.00: Introduction
  156. 18.01: Hypertension and Angina
  157. 18.02: Angiotensin-Converting Enzyme (ACE) Inhibitors
  158. 18.03: Angiotensin II Receptor Blockers (ARBs)
  159. 18.04: Beta-Adrenergic Blockers
  160. 18.05: Calcium Channel Blockers
  161. 18.06: Diuretics
  162. 18.07: Nitrates
  163. 18.08: Chapter Summary
  164. 18.09: Key Terms
  165. 18.10: Review Questions
  166. 19: Heart Failure Drugs
  167. 19.00: Introduction
  168. 19.01: Heart Failure
  169. 19.02: Drugs Affecting the Renin-Angiotensin-Aldosterone System
  170. 19.03: Beta-Adrenergic Blockers
  171. 19.04: Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is)
  172. 19.05: Diuretics
  173. 19.06: Adjunct Medications Used in Heart Failure
  174. 19.07: Chapter Summary
  175. 19.08: Key Terms
  176. 19.09: Review Questions
  177. 20: Anticoagulant Antiplatelet and Thrombolytic Drugs
  178. 20.00: Introdcution
  179. 20.01: Introduction to Clotting and Coagulation
  180. 20.02: Anticoagulants
  181. 20.03: Antiplatelets
  182. 20.04: Thrombolytics
  183. 20.05: Chapter Summary
  184. 20.06: Key Terms
  185. 20.07: Review Questions
  186. 21: Lipid-Lowering Drugs
  187. 21.00: Introduction
  188. 21.01: Introduction to Lipoprotein and Apolipoproteins
  189. 21.02: Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
  190. 21.03: Bile Acid Sequestrants Fibrates and Niacin
  191. 21.04: Cholesterol Absorption Inhibitors
  192. 21.05: Chapter Summary
  193. 21.06: Key Terms
  194. 21.07: Review Questions
  195. 22: Cardiac Emergency and Shock Drugs
  196. 22.00: Introduction
  197. 22.01: Introduction to Cardiac Emergencies and Shock
  198. 22.02: Cardiac Emergency Drugs
  199. 22.03: Shock Drugs
  200. 22.04: Chapter Summary
  201. 22.05: Key Terms
  202. 22.06: Review Questions
  203. 23: Introduction to the Respiratory System
  204. 23.00: Introduction
  205. 23.01: Introduction to the Upper Respiratory System
  206. 23.02: Introduction to the Lower Respiratory System
  207. 23.03: Oxygenation and Gas Exchange
  208. 23.04: Chapter Summary
  209. 23.05: Key Terms
  210. 23.06: Review Questions
  211. 24: Upper Respiratory Disorder Drugs
  212. 24.00: Introduction
  213. 24.01: Antihistamines and Decongestants
  214. 24.02: Antitussives
  215. 24.03: Expectorants and Mucolytics
  216. 24.04: Chapter Summary
  217. 24.05: Key Terms
  218. 24.06: Review Questions
  219. 25: Lower Respiratory Disorder Drugs
  220. 25.00: Introduction
  221. 25.01: Adrenergics and Anticholinergics
  222. 25.02: Corticosteroids
  223. 25.03: Xanthines Leukotriene Modifiers and Mast Cell Stabilizers
  224. 25.04: Chapter Summary
  225. 25.05: Key Terms
  226. 25.06: Review Questions
  227. 26: Hypothalamus Pituitary and Adrenal Disorder Drugs
  228. 26.00: Introduction
  229. 26.01: Introduction to the Adrenal Cortex Pituitary and Hypothalamus
  230. 26.02: Growth Hormones and Suppressants
  231. 26.03: Antidiuretic Hormones
  232. 26.04: Glucocorticoids and Mineralocorticoids
  233. 26.05: Chapter Summary
  234. 26.06: Key Terms
  235. 26.07: Review Questions
  236. 27: Thyroid and Parathyroid Disorder Drugs
  237. 27.00: Introduction
  238. 27.01: Introduction to the Thyroid and Parathyroid
  239. 27.02: Thyroid and Antithyroid Drugs
  240. 27.03: Calcium Preparations Vitamin D Bisphosphonates Calcimimetics and Peptide Hormones
  241. 27.04: Chapter Summary
  242. 27.05: Key Terms
  243. 27.06: Review Questions
  244. 28: Diabetic Drugs
  245. 28.00: Introduction
  246. 28.01: Introduction to Diabetes
  247. 28.02: Insulin and Non-Insulin Injectable Diabetes Drugs
  248. 28.03: Oral Antidiabetic Drugs
  249. 28.04: Chapter Summary
  250. 28.05: Key Terms
  251. 28.06: Review Questions
  252. 29: Introduction to the Digestive System
  253. 29.00: Introduction
  254. 29.01: Introduction to the Gastrointestinal System and Oral Cavity
  255. 29.02: Introduction to the Esophagus and Stomach
  256. 29.03: Introduction to the Small and Large Intestines
  257. 29.04: Chapter Summary
  258. 29.05: Key Terms
  259. 29.06: Review Questions
  260. 30: Gastrointestinal Disorder Drugs
  261. 30.00: Introduction
  262. 30.01: Antiemetics
  263. 30.02: Antidiarrheals
  264. 30.03: Laxatives and Stool Softeners
  265. 30.04: Chapter Summary
  266. 30.05: Key Terms
  267. 30.06: Review Questions
  268. 31: Hyperacidity and Antiulcer Drugs
  269. 31.00: Introduction
  270. 31.01: Antacids
  271. 31.02: Histamine Blockers and Proton-Pump Inhibitors
  272. 31.03: Pepsin Inhibitors and Prostaglandin Analogues
  273. 31.04: Chapter Summary
  274. 31.05: Key Terms
  275. 31.06: Review Questions
  276. 32: Weight Management Drugs
  277. 32.00: Introduction
  278. 32.01: Introduction to Weight Management
  279. 32.02: Anorexiants
  280. 32.03: Lipase Inhibitors
  281. 32.04: Other Drugs Supplements and Herbal Remedies
  282. 32.05: Chapter Summary
  283. 32.06: Key Terms
  284. 32.07: Review Questions
  285. 33: Introduction to the Renal and Urinary Systems
  286. 33.00: Introduction
  287. 33.01: Introduction to the Renal System
  288. 33.02: Renal-Associated Fluid Volume Excess
  289. 33.03: Introduction to the Urinary System
  290. 33.04: Chapter Summary
  291. 33.05: Key Terms
  292. 33.06: Review Questions
  293. 34: Diuretic Drugs
  294. 34.00: Introduction
  295. 34.01: Introduction to Diuretics
  296. 34.02: Loop Diuretics
  297. 34.03: Osmotic Diuretics
  298. 34.04: Potassium-Sparing Diuretics
  299. 34.05: Thiazide and Thiazide-Like Diuretics
  300. 34.06: Chapter Summary
  301. 34.07: Key Terms
  302. 34.08: Review Questions
  303. 35: Urinary and Bladder Disorder Drugs
  304. 35.00: Introduction
  305. 35.01: Urinary Anti-infectives
  306. 35.02: Urinary Antispasmodics Antimuscarinics and Anticholinergics
  307. 35.03: Urinary Analgesics
  308. 35.04: Urinary Stimulants
  309. 35.05: Phosphodiesterase 5 Inhibitors
  310. 35.06: Chapter Summary
  311. 35.07: Key Terms
  312. 35.08: Review Questions
  313. 36: Reproductive Health Drugs
  314. 36.00: Introduction
  315. 36.01: Review of the Female Reproductive System
  316. 36.02: Hormonal Contraception and Infertility Drugs
  317. 36.03: Uterine Motility Drugs and Lactation Considerations
  318. 36.04: Bisphosphonates Calcium Preparations Vitamin D and Estrogen Receptor Modulators
  319. 36.05: Review of the Male Reproductive System
  320. 36.06: Androgens Antiandrogens and Anabolic Steroids
  321. 36.07: Phosphodiesterase 5 Inhibitors
  322. 36.08: Alpha Blockers and 5-Alpha-Reductase Inhibitors
  323. 36.09: Chapter Summary
  324. 36.10: Key Terms
  325. 36.11: Review Questions
  326. 37: Transgender and Nonbinary Drugs
  327. 37.00: Introduction
  328. 37.01: Overview of Transgender and Nonbinary Health
  329. 37.02: Feminizing Hormonal Therapy
  330. 37.03: Masculinizing Hormonal Therapy
  331. 37.04: Chapter Summary
  332. 37.05: Key Terms
  333. 37.06: Review Questions
  334. 38: Ophthalmic Drugs
  335. 38.00: Introduction
  336. 38.01: Introduction to the Eyes
  337. 38.02: Ocular Anti-inflammatories and Anti-infectives
  338. 38.03: Ocular Anesthetics and Lubricants
  339. 38.04: Antiglaucoma Drugs
  340. 38.05: Chapter Summary
  341. 38.06: Key Terms
  342. 38.07: Review Questions
  343. 39: Otic Drugs
  344. 39.00: Introduction
  345. 39.01: Introduction to the Ears
  346. 39.02: Otic Anti-inflammatories and Anti-infectives
  347. 39.03: Otic Antihistamines Decongestants and Cerumenolytics
  348. 39.04: Chapter Summary
  349. 39.05: Key Terms
  350. 39.06: Review Questions
  351. 40: Dermatologic Disorder Drugs
  352. 40.00: Introduction
  353. 40.01: Introduction to the Skin and Its Function
  354. 40.02: Acne Drugs
  355. 40.03: Psoriatic Drugs
  356. 40.04: Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
  357. 40.05: Chapter Summary
  358. 40.06: Key Terms
  359. 40.07: Review Questions
  360. 41: Appendix
  361. 41.00: Appendix A- International System of Units
  362. 41.01: Appendix B- Common Abbreviations and Lab Values
  363. 41.02: Appendix C- Drug Conversion Tables
  364. 41.03: Answer Key
  365. 41.3.00: Chapter 1
  366. 41.3.01: Chapter 2
  367. 41.3.02: Chapter 3
  368. 41.3.03: Chapter 4
  369. 41.3.04: Chapter 5
  370. 41.3.05: Chapter 6
  371. 41.3.06: Chapter 7
  372. 41.3.07: Chapter 8
  373. 41.3.08: Chapter 9
  374. 41.3.09: Chapter 10
  375. 41.3.10: Chapter 11
  376. 41.3.11: Chapter 12
  377. 41.3.12: Chapter 13
  378. 41.3.13: Chapter 14
  379. 41.3.14: Chapter 15
  380. 41.3.15: Chapter 16
  381. 41.3.16: Chapter 17
  382. 41.3.17: Chapter 18
  383. 41.3.18: Chapter 19
  384. 41.3.19: Chapter 20
  385. 41.3.20: Chapter 21
  386. 41.3.21: Chapter 22
  387. 41.3.22: Chapter 23
  388. 41.3.23: Chapter 24
  389. 41.3.24: Chapter 25
  390. 41.3.25: Chapter 26
  391. 41.3.26: Chapter 27
  392. 41.3.27: Chapter 28
  393. 41.3.28: Chapter 29
  394. 41.3.29: Chapter 30
  395. 41.3.30: Chapter 31
  396. 41.3.31: Chapter 32
  397. 41.3.32: Chapter 33
  398. 41.3.33: Chapter 34
  399. 41.3.34: Chapter 35
  400. 41.3.35: Chapter 36
  401. 41.3.36: Chapter 37
  402. 41.3.37: Chapter 38
  403. 41.3.38: Chapter 39
  404. 41.3.39: Chapter 40
  405. 41.04: References